0001209191-21-004994.txt : 20210122 0001209191-21-004994.hdr.sgml : 20210122 20210122210129 ACCESSION NUMBER: 0001209191-21-004994 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210121 FILED AS OF DATE: 20210122 DATE AS OF CHANGE: 20210122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoelscher Paul W. CENTRAL INDEX KEY: 0001611468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 21547632 MAIL ADDRESS: STREET 1: 520 LAKE COOK ROAD, SUITE 520 STREET 2: C/O HORIZON PHARMA, INC. CITY: DEERFIELD STATE: IL ZIP: 60062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-21 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001611468 Hoelscher Paul W. C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP, CFO Ordinary Shares 2021-01-19 5 G 0 E 169132 0.00 D 1049 D Ordinary Shares 2021-01-19 5 G 0 E 169132 0.00 A 272057 I By Trust Ordinary Shares 2021-01-21 4 M 0 5556 0.00 A 6605 D Ordinary Shares 2021-01-21 4 F 0 2462 77.43 D 4143 D Performance Restricted Stock Units (PSUs) 2021-01-21 4 M 0 5556 0.00 D Ordinary Shares 5556 5558 D Each PSU represents a contingent right to receive one ordinary share of the Issuer. The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022. /s/ Miles W. McHugh, Attorney-in-Fact 2021-01-22